Advertisement

Topics

EU clears Roche’s Ocrevus for MS

04:58 EST 12 Jan 2018 | PharmaTimes

Roche’s Ocrevus has been approved for use in Europe to treat adults with relapsing multiple sclerosis (RMS) and early primary progressive multiple sclerosis (PPMS).

Original Article: EU clears Roche’s Ocrevus for MS

NEXT ARTICLE

More From BioPortfolio on "EU clears Roche’s Ocrevus for MS"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...